BID Product definition

BID Product means the 200mg, 400mg or 600mg standalone tablets (and specifically excluding capsules) that contain the Compound as the active ingredient and are to be taken twice daily.
View Source
BID Product means a 200mg, 400mg or 600mg, as applicable, standalone tablet (and specifically excluding capsules) that (a) contains Ribavirin as the active ingredient, and (b) is to be taken twice daily.
View Source
BID Product means any Product formulated for twice daily (BID) injectable administration in a single injection delivery mechanism.
View Source

Examples of BID Product in a sentence

  • With respect to the BID Product, AbbVie shall coordinate with Kadmon and provide any Marketing Materials in advance to Kadmon for review.

  • Notwithstanding the foregoing or anything to the contrary herein, (a) no Royalty Payment will be due and owing for the BID Product or Co-Packaged Product (but only with respect to product co- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT.

  • Kadmon shall cooperate with AbbVie in giving full effect to any investigation and/or recall as it relates to the BID Product component of an Exclusive Product.

  • AbbVie shall, with support from Kadmon (including Kadmon’s submission of appropriate documentation to enable AbbVie to), obtain all necessary advanced regulatory review and approval of Marketing Materials developed after the Effective Date by AbbVie for the BID Product, including submitting such Marketing Materials to the Office of Prescription Drug Promotion, and shall provide copies of the Marketing Materials so submitted to Kadmon for its records.

  • Kadmon shall forward to AbbVie all regulatory documents intended for submission with the applicable Governmental Authority and directed specifically to BID Product fifteen (15) Business Days prior to such submission.

  • Subject to the terms of this Agreement, for calendar years 2015 and 2016 only (the “Initial Royalty Term”), AbbVie will pay Kadmon a royalty based on the number of prescriptions of High Dose BID Product dispensed for use with any other approved product sold by AbbVie for the treatment of Hepatitis C virus during each such calendar year in the Territory (the “High Dose BID Royalty”), as evidenced by the Prescription Data (as defined below) and calculated pursuant to the Royalty Formula (as defined below).

  • Notwithstanding the foregoing, with respect to BID Product Commercialized by AbbVie hereunder, Kadmon is obligated to submit such materials to Governmental Authorities as AbbVie may provide from time-to-time to enable AbbVie’s Commercialization of BID Product, and Kadmon shall take all such actions as are necessary to enable AbbVie to communicate with Governmental Authorities with respect to such BID Product and related materials.

  • At all such meetings and conferences AbbVie shall have the right to attend as an observer to the extent permitted by Governmental Authorities; provided that AbbVie shall be permitted to contribute and participate in interactions during such meetings as they pertain to BID Product Commercialized by AbbVie hereunder.

  • However, should such communication relate to the safety of BID Product, Kadmon shall forward such communication to AbbVie within twenty-four (24) CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT.

  • Effective as to expenses accrued on or after January 1, 2007, Lilly shall also be solely responsible for 100% of BID Product Development Costs relating to Development of BID Product for sale outside of the U.S. (including without limitation OUS BID Development Trial Costs).


More Definitions of BID Product

BID Product means the Product sold under the Product Trademark “BYETTA®” (or such other Trademark if BYETTA is unavailable as a Trademark in a given country) as a fixed-dose injection of exenatide administered twice per day for any indication provided for in the first Marketing Approval received in a relevant country (included in such indication would be any subsequent label expansion(s) relating to use of the BID Product for the same indication, e.g., new indication for combination use with TZDs for treatment of the same indication as provided for in the first Marketing Approval). For the avoidance of doubt, it is understood that any subsequent indication relating to any disease or condition not included in the first Marketing Approval shall be regarded as a Non-BID Product (e.g., a Product indicated for treatment of obesity or Type I diabetes is a Non-BID Product).
View Source
BID Product means the Product being studied in the Amigo Trials.
View Source

Related to BID Product

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Generic Product means any pharmaceutical product that (i) is sold by a Third Party that is not an Affiliate or licensee of Buyer and (ii) (a) contains the same active pharmaceutical ingredient as the Product or (b) is categorized by the applicable Governmental Entity in a country to be therapeutically equivalent to, or interchangeable with, the Product, such that the pharmaceutical product may be substituted for the Product at the point of dispensing without any intervention by the prescribing physician in such country.

  • Competing Product means [***].

  • Finished Product means the final packaged product intended for human consumption;